Enliven Therapeutics Balance Sheet (2019-2026) | ELVN

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
75.30M48.31M99.88M92.46M86.16M75.54M292.10M125.72M73.85M100.14M149.16M96.87M100.62M124.12M101.70M119.44M101.73M98.90M132.18M135.50M
Short-term Investments (Quarter)
27.54M41.97M36.42M29.91M6.81M152.15M189.63M153.01M171.34M0.05M0.05M189.32M363.73M320.22M759.65M
Cash & Current Investments (Quarter)
102.84M90.28M136.29M122.36M92.97M75.54M292.10M277.87M263.48M253.15M320.50M96.92M100.67M313.44M101.70M119.44M101.73M462.62M452.40M895.15M
Prepaid Assets (Quarter)
3.16M2.42M5.63M3.92M2.80M2.22M5.90M5.31M5.13M2.95M6.64M5.68M5.11M4.63M4.76M5.12M5.12M12.26M10.74M12.18M
Current Assets (Quarter)
106.00M92.70M78.53M64.26M59.10M77.75M298.00M283.18M268.61M266.15M337.20M318.13M297.00M318.13M294.32M495.62M482.68M474.88M463.14M907.34M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.28M0.25M0.59M0.10M0.89M0.85M0.87M0.81M0.74M0.68M0.63M0.55M0.46M0.40M0.46M0.40M0.03M0.02M0.14M
Other Non-Current Assets (Quarter)
0.17M0.17M0.17M0.17M0.05M0.05M3.41M0.05M4.09M4.09M7.56M7.24M7.17M7.20M7.24M7.10M0.66M1.19M1.24M
Non-Current Assets (Quarter)
1.03M0.95M3.07M0.41M5.54M4.86M5.33M5.43M5.72M5.58M8.92M8.43M7.63M8.25M8.27M8.19M1.29M1.72M2.88M
Assets (Quarter)
107.03M93.65M81.60M64.67M59.10M83.30M302.87M288.50M274.04M271.87M342.78M327.04M305.43M325.76M302.57M503.89M490.88M476.17M464.85M910.22M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.48M2.36M1.88M1.14M0.77M3.44M5.86M2.84M1.49M0.53M2.73M1.08M1.02M1.34M1.56M2.35M1.43M2.16M1.64M0.37M
Payables (Quarter)
2.48M2.36M1.88M1.14M0.77M3.44M5.86M2.84M1.49M0.53M2.73M1.08M1.02M1.34M1.56M2.35M1.43M2.16M1.64M0.37M
Accumulated Expenses (Quarter)
4.46M4.60M4.83M1.72M1.05M6.28M5.08M1.78M2.64M15.36M1.81M11.82M3.48M14.57M12.41M12.86M13.22M4.29M2.26M13.79M
Other Accumulated Expenses (Quarter)
0.45M0.55M0.34M0.37M0.36M0.45M0.29M0.22M0.20M0.15M0.06M0.09M0.35M0.11M0.13M
Current Leases (Quarter)
0.25M0.25M0.51M0.45M0.32M0.33M0.33M0.34M0.25M0.17M0.09M0.36M0.38M0.39M0.40M0.30M0.60M
Current Taxes (Quarter)
0.23M
Total Current Liabilities (Quarter)
7.19M7.21M7.22M3.30M1.82M9.71M10.94M9.15M12.08M25.89M25.03M22.11M17.03M15.91M13.97M15.21M14.65M16.57M11.49M14.16M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
0.47M0.41M1.97M
Other Non-Current Liabilities (Quarter)
0.66M0.51M0.36M0.21M0.07M0.03M0.01M0.30M0.20M0.10M0.91M
Total Non-Current Liabilities (Quarter)
9.71M10.94M9.15M12.08M25.89M25.03M22.11M17.03M15.91M13.97M15.21M14.65M16.57M14.16M
Total Liabilities (Quarter)
7.65M7.62M9.19M3.30M1.82M10.37M11.45M9.51M12.29M25.96M25.07M22.11M17.03M15.91M14.27M15.41M14.75M16.57M11.49M15.07M
Shareholder's Equity
Common Equity (Quarter)
99.37M-42.89M-50.61M-58.71M-68.10M-76.83M291.42M278.99M261.75M245.91M317.71M304.93M288.40M309.85M288.30M488.47M476.12M459.60M453.37M895.15M
Liabilities and Shareholders Equity (Quarter)
107.03M93.65M81.60M64.67M59.10M83.30M302.87M288.50M274.04M271.87M342.78M327.04M305.43M325.76M302.57M503.89M490.88M476.17M464.85M910.22M
Retained Earnings (Quarter)
-133.20M-147.50M-162.14M-0.04M-178.19M6.04M-97.60M-0.11M-135.08M400.17M-177.19M502.16M0.24M-243.47M-272.00M-297.40M0.22M0.33M-370.79M1,300.26M
Preferred Shares (Quarter)
149.75M
Treasury Shares (Quarter)
0.10M0.43M0.24M0.21M0.04M0.03M0.02M0.08M0.10M0.09M0.09M0.08M0.10M0.09M0.08M0.08M0.32M0.36M